Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BLEOMYCIN Cause Neuropathy peripheral? 137 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 137 reports of Neuropathy peripheral have been filed in association with BLEOMYCIN (Bleomycin). This represents 2.0% of all adverse event reports for BLEOMYCIN.

137
Reports of Neuropathy peripheral with BLEOMYCIN
2.0%
of all BLEOMYCIN reports
16
Deaths
20
Hospitalizations

How Dangerous Is Neuropathy peripheral From BLEOMYCIN?

Of the 137 reports, 16 (11.7%) resulted in death, 20 (14.6%) required hospitalization, and 8 (5.8%) were considered life-threatening.

Is Neuropathy peripheral Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BLEOMYCIN. However, 137 reports have been filed with the FAERS database.

What Other Side Effects Does BLEOMYCIN Cause?

Off label use (656) Febrile neutropenia (632) Neutropenia (433) Drug ineffective (395) Pyrexia (291) Product use in unapproved indication (280) Pulmonary toxicity (263) Thrombocytopenia (260) Nausea (255) Anaemia (252)

What Other Drugs Cause Neuropathy peripheral?

LENALIDOMIDE (10,215) BORTEZOMIB (4,067) OXALIPLATIN (3,662) DEXAMETHASONE (3,543) PACLITAXEL (3,508) LEVOFLOXACIN (2,619) CIPROFLOXACIN (2,607) FLUOROURACIL (2,605) CYCLOPHOSPHAMIDE (2,565) POMALIDOMIDE (2,382)

Which BLEOMYCIN Alternatives Have Lower Neuropathy peripheral Risk?

BLEOMYCIN vs BLINATUMOMAB BLEOMYCIN vs BLONANSERIN BLEOMYCIN vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 BLEOMYCIN vs BOCEPREVIR BLEOMYCIN vs BOCOCIZUMAB

Related Pages

BLEOMYCIN Full Profile All Neuropathy peripheral Reports All Drugs Causing Neuropathy peripheral BLEOMYCIN Demographics